Our primary listing is on the London Stock Exchange. We have also listed Global Depositary Receipts on the NASDAQ Dubai and the Bank of New York Mellon acts as depositary for our American Depositary Receipt programme.
The Company's primary listing and ordinary shares are admitted to the Official List of the London Stock Exchange.
EPIC: HIK
SEDOL: B0LCW08 GB
ISIN: GB00B0LCW083
Further information on this market, its trading systems and current trading in Hikma's shares can be found on the London Stock Exchange website which can be accessed at: www.londonstockexchange.com
Hikma Pharmaceuticals PLC has an ADR programme for which Bank of New York Mellon acts as Depositary. One ADR equates to 2 Hikma ordinary shares. ADRs are traded as a Level 1 Over-The-Counter ("OTC") programme under the symbol HKMPY.
Enquiries should be made to:
BNY Mellon Shareowner Services
PO Box 43006
Providence RI 02940-3078
Overnight Correspondence:
BNY Mellon Shareowner Services, 150 Royall St., Suite 101 Canton, MA 02021
Tel: +1 201 680 6825 (international)
Tel: +1 888-269-2377 (toll-free within the US)
E-mail: shrrelations@cpushareownerservices.com
www.mybnymdr.com
Hikma Pharmaceuticals PLC also has listed GDRs on NASDAQ Dubai for which Citibank acts as Depositary. They are listed under EPIC – HIK and ISIN – US4312882081.
Enquiries should be made to:
Citibank N.A. GDR Depositary Bank Citibank Shareholder Services
Address: P.O. Box 43077, Providence,
Rhode Island 02940-3077, US
Telephone: 1 877 CITI ADR (toll-free)
Telephone: 1 781 575 4555 (out of US)
Email: citibank@shareholders-online.com
Further information on NASDAQ Dubai, its trading systems and current trading in Hikma Pharmaceuticals PLC GDRs can be found on the website www.nasdaqdubai.com